Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05514912
Title Preoperative Nab-paclitaxel, Cisplatin, and Gemcitabine Chemotherapy With or Without Infigratinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, The OPTIC Trial
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Emory University

intrahepatic cholangiocarcinoma


Cisplatin + Gemcitabine + Nab-paclitaxel

Cisplatin + Gemcitabine + Infigratinib + Nab-paclitaxel

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST